(282 days)
The END-200 Tubeset is intended to be used with the EVA15 insufflator, to supply CO2 to an endoscope during gastrointestinal endoscopic procedures.
The END-200 Tubeset is a dual lumen tube with clips that attach to the outside of an endoscope. It connects to a CO2 gas source and is used to insufflate the cavity during an endoscopic procedure, and to provide a line to monitor pressure. It is single use, disposable and provided non-sterile similar to the predicate. The ENDO-200 Tubeset is offered in Small and Medium sizes.
The document provided is a 510(k) summary for the END-200 Tubeset, a medical device. It does not describe a study involving an AI algorithm or its performance criteria, but rather focuses on demonstrating substantial equivalence to a predicate device. Therefore, most of the requested information about AI study design and performance criteria is not applicable to this document.
However, I can extract the non-clinical testing performed and the general acceptance of the device based on that testing.
1. A table of acceptance criteria and the reported device performance
Based on the provided document, specific numerical acceptance criteria are not explicitly stated. Instead, the document mentions that the device "met its performance acceptance criteria" after testing.
| Acceptance Criteria (General) | Reported Device Performance |
|---|---|
| Does not affect delivery pressure accuracy of the insufflator. | "met its performance acceptance criteria." (Implying it did not affect accuracy.) |
| Compatible with the endoscope system. | Demonstrated to be compatible. |
| Tubeset remained attached to the endoscope during use. | Remained attached. |
| Device could be maneuvered as intended. | Could be maneuvered as intended. |
| Did not cause any tissue injury during use. | Did not cause any tissue injury. |
| Biocompatibility (Cytotoxicity, Sensitization, and Irritation) for mucosal, limited duration contact according to ISO 10993 standards. | Passed ISO 10993-5 (Cytotoxicity) and ISO 10993-10 (Sensitization and Irritation). |
2. Sample size used for the test set and the data provenance (e.g., country of origin of the data, retrospective or prospective)
- Sample Size for Test Set: This information is not specified in the document for any of the non-clinical or animal testing.
- Data Provenance: Not specified. The document only mentions "Bench Testing" and "Animal Testing."
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
This information is not applicable as the document describes non-clinical and animal testing for a physical medical device, not an AI algorithm requiring expert ground truth for image interpretation or similar.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
This information is not applicable as the document describes non-clinical and animal testing for a physical medical device.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
This information is not applicable as no AI algorithm is mentioned or studied in the provided document.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
This information is not applicable as no AI algorithm is mentioned or studied in the provided document.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
For the non-clinical testing:
- Bench Testing: The ground truth would be established by the engineering specifications and measurement standards for pressure accuracy.
- Animal Testing: The ground truth would be based on direct observation of the device's function, attachment, maneuverability, and assessment of tissue for injury by qualified animal study personnel (e.g., veterinarians, pathologists).
- Biocompatibility Testing: The ground truth is laboratory testing results conforming to ISO 10993 standards.
8. The sample size for the training set
This information is not applicable as no AI algorithm is mentioned or studied in the provided document.
9. How the ground truth for the training set was established
This information is not applicable as no AI algorithm is mentioned or studied in the provided document.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left, there is a symbol representing the Department of Health & Human Services - USA. To the right of this symbol, there is a blue square with the letters "FDA" in white. Next to the blue square, the words "U.S. FOOD & DRUG ADMINISTRATION" are written in blue.
July 8, 2021
Palliare Ltd. % Paul Dryden Consultant Palliare Ltd. c/o ProMedic Consulting, LLC 131 Bay Point Dr. NE St. Petersburg, FL 33704
Re: K202922
Trade/Device Name: END 200 Tubeset Regulation Number: 21 CFR 876.1500 Regulation Name: Endoscope and accessories Regulatory Class: Class II Product Code: FCX Dated: June 6, 2021 Received: June 8, 2021
Dear Paul Dryden:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
{1}------------------------------------------------
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
for
Shanil P. Haugen, Ph.D. Assistant Director DHT3A: Division of Renal, Gastrointestinal, Obesity and Transplant Devices OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known)
K202922
Device Name
END-200 Tubeset
Indications for Use (Describe)
The END-200 Tubeset is intended to be used with the EVA15 insufflator, to supply CO2 to an endoscope during gastrointestinal endoscopic procedures.
Type of Use (Select one or both, as applicable)
XX Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not respond to, a collection of information unless it displays a currently valid OMB number."
FORM FDA 3881 (6/20)
Page 1 of 1
EF PSC Publishing Services (301) 443-6740
{3}------------------------------------------------
| Page 1 of 4 | |
|---|---|
| -- | ------------- |
| Date Prepared: | 7-Jul-2021 |
|---|---|
| ---------------- | ------------ |
Palliare Ltd.
Galway Business Park, Dangan
Galway H91 P2DK, Ireland
| Official Contact: | John O'Dea, Ph.D., Director |
|---|---|
| Submission Correspondent: | Paul DrydenProMedic, LLC |
| Device Name: | END-200 Tubeset |
| Common Name: | Endoscope and accessories |
| Regulation Number: | 21CFR 876.1500 |
| Regulation Name: | Endoscope and accessories |
| Product Code: | FCX |
| Regulatory Class: | II |
| Device Panel: | Gastroenterology/Urology |
| Predicate Device: | K053008 – E-Z-EM, Inc. – E-Z-EM Endoscopic CO2 regulator |
| Reference Device: | K163614 - Pentax Medical - PENTAX Medical ED34-i10T, Video Duodenoscope |
510(k) Summary
Device Description:
The END-200 Tubeset is a dual lumen tube with clips that attach to the outside of an endoscope. It connects to a CO2 gas source and is used to insufflate the cavity during an endoscopic procedure, and to provide a line to monitor pressure. It is single use, disposable and provided non-sterile similar to the predicate. The ENDO-200 Tubeset is offered in Small and Medium sizes.
Principle of Operation:
The device is a simple dual lumen conduit from an insufflator to an anatomical cavity being insufflated. One lumen is used when monitoring pressure in the cavity and the other lumen is used to delivered CO2 from the insufflator.
Indications for Use:
The END-200 Tubeset is intended to be used with the EVA15 insufflator, to supply CO2 to an endoscope during gastrointestinal endoscopic procedures.
Patient Population:
Patients undergoing endoscopic procedures in which insufflation may be helpful.
Environments of use:
Operating room or endoscopy suite.
Table 1 is a comparison - Subject Device vs. the Predicate, K053008 and includes a discussion of the reference device, K163614.
{4}------------------------------------------------
510(k) Summary Page 2 of 4
Table 1 – Comparison – Subject vs. Predicate / Reference
| Predicate:EZ-EM, Inc. – E-Z-EMEndoscopic CO2 regulatorK053008 | ReferencePENTAX Medical ED34-i10T,Video Duodenoscope accessoryK163614 | Proposed Device:END-200 Tubeset | Comparison | |
|---|---|---|---|---|
| Manufacturer | E-ZEM, Inc. (now BraccoDiagnostics, Inc) | Pentax Medical | Palliare | |
| Classification | 21 C.F.R. § 876.1500Product Code - FCX | 21 C.F.R. § 876.1500Product Code - FDT | 21 C.F.R. § 876.1500Product Code - FCX | Similar.The reference is forthe external accessoryreference only. |
| Fundamental scientifictechnology | Tube that connects to theendoscope and delivers CO2 duringendoscopic procedures | Detachable Distal Cap | Tube that connects to theendoscope and delivers CO2 duringendoscopic procedures | Same |
| Indications for Use | The CO2 endoscopic Insufflator In-line tubing set is intended toconnect a CO2 source (insufflator),and a sterile water source (waterbottle), to an endoscope to supplyCO2 during gastrointestinalendoscopic procedures. | The PENTAX DuodenoscopeED34-i10T is intended to provideoptical visualization of (via avideo monitor), andtherapeutic access to, BiliaryTract via the UpperGastrointestinal Tract. Thisanatomy includes, but is notrestricted to, theorgans; tissues; and subsystems:Esophagus, Stomach,Duodenum, Common Bile,Hepatic and Cystic Ducts.These instruments are introducedvia the mouth when indicationsconsistent with the need for theprocedure are observed in adultand pediatric patient populations. | The END-200 tubeset is intendedto be used with the EVA15insufflator, to supply CO2 to anendoscope during gastrointestinalendoscopic procedures. | Similar exceptsubject device is notconnected to watersourceWith regards to thereference we are onlyreferring to theexternal cap whichhas a similar designas an externalaccessory to theendoscope. |
| Compatibility | Connects to OEM Endoscopesystems that are equipped with anexternal luer connector | Connects to endoscope systems | Connects to OEM Endoscopesystems | Same |
| Sterile | Non-sterile | Sterilized prior to use | Non-sterile | Same |
| Disposable | Single patient use, disposable | Single patient use, disposable | Single patient use, disposable | Same |
| Shelf-life | 6 years | Not stated | 1 year | Similar |
| Biocompatibility | ISO 10993-1 | ISO 10993-1 | ISO 10993-1 | Similar |
| Surface Contact, mucosa, limitedduration | Surface Contact, mucosa, limitedduration | Surface Contact, mucosa, limitedduration |
{5}------------------------------------------------
510(k) Summary Page 3 of 4
Substantial Equivalence Discussion
The END-200 Tubeset has the same general indications, technological characteristics, and principles of operation as the predicate.
Intended Use/ Indications for Use
The proposed indications for use are similar to the predicate.
Technological Characteristics
The technology of a set of tubing with connectors that can endoscope and deliver CO2 as desired for insufflation is similar to the predicate.
{6}------------------------------------------------
Principles of Operation
The principle of operation of providing a conduit to delivery gas for insufflation is similar to the predicate.
Non-clinical Testing Bench Testing
Performance testing was conducted to ensure that the tubing does not affect the delivery pressure accuracy of the insufflator. The subject device was tested and met its performance acceptance criteria.
Animal Testing
Animal testing demonstrated that the tubeset device is compatible with the endoscope system, the tubeset remained attached to the endoscope during use, the device could be maneuvered as intended and did not cause any tissue injury during use.
Biocompatibility
Biocompatibility testing of the patient contacting materials included ISO 10993-5 - Cytotoxicity and ISO 10993-10 - Sensitization and Irritation as a Surface Contacting, Mucosal, Limited Duration of Use device.
Substantial Equivalence Conclusion
The comparison and testing demonstrate that the subject device is substantially equivalent to the predicate and that there are no new questions of safety or effectiveness raised when compared to the predicate.
§ 876.1500 Endoscope and accessories.
(a)
Identification. An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.(b)
Classification —(1)Class II (special controls). The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.